Incyte | INCY - Ebit

Биржевая цена
95.29
Изменение за день
-3.81 -3.84%
Ежемесячно
1.24%
Ежегодный
53.62%
Q2 прогноз
92.62




Ebit Изменить Дата
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agenus USD 14.4M 19.26M 2025-12
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amgen USD 3.96B 464M 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Biogen USD 514.3M 502.8M 2026-03
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Exelixis USD 235.91M 20.45M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Incyte USD 383.88M 47.44M 2025-12
Ionis Pharmaceuticals USD -118M 97M 2026-03
MacroGenics USD -12.1M 32.26M 2025-12
Merck USD 6.24B 1.32B 2025-12
Moderna USD -857M 597M 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.06B 530M 2025-12
Novartis USD 4.06B 413M 2025-12
Pfizer USD 4.65B 71M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12